🕵️ NRX Pharmaceuticals, Inc. ($NRXP)
SEC insider & ownership activity, last 12 months · CIK 1719406 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Jan 12, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| The B Group, Inc. | 12.6% | 13G | Aug 21, 2025 | filing ↗ | |
| B Group Capital LLC | 12.6% | 13G | Aug 21, 2025 | filing ↗ | |
| Branden B. Muhl | 12.6% | 13G | Aug 21, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 21, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 3, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Other events (8.01) | Jun 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 23, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Other events (8.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 27, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Auditor change (4.01) | Nov 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 20, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Oct 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Sep 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Sep 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 8, 2025 | filing ↗ |